Search results
Results from the WOW.Com Content Network
Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations.The preparation is a macromolecular complex, consisting of iron(III) hydroxide (trivalent iron, Fe 3+, Fe(OH) 3 ·H 2 O) and the carrier polymaltose and is available in solid form as a film-coated or chewable tablet and in liquid form ...
[2] [6] A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice, while also achieving a cost saving. [7] By 2003, issue 46 of the BNF contained 3000 interactions or groups of interactions, with about 900 of these marked by a bullet. [8] [9 ...
Developmental disability is a diverse group of chronic conditions, comprising mental or physical impairments that arise before adulthood. Developmental disabilities cause individuals living with them many difficulties in certain areas of life, especially in "language, mobility, learning, self-help, and independent living". [1]
The plan targeted $1.059 billion in U.S. sales for 2000, through 707,000 in-person sales calls to doctors who would prescribe 452 million pills or oral doses, priced at about $2.50 per dose. Total costs—including $51 million for “public relations, grants, sales support and medical education programs,” and $14.3 million for free samples ...
A medical professional administering nose drops Instillation of eye drops. A topical medication is a medication that is applied to a particular place on or in the body. Most often topical medication means application to body surfaces such as the skin or mucous membranes to treat ailments via a large range of classes including creams, foams, gels, lotions, and ointments. [1]
Intellectual disability affects about 2–3% of the general population. [11] Seventy-five to ninety percent of the affected people have mild intellectual disability. [11] Non-syndromic, or idiopathic cases account for 30–50% of these cases. [11] About a quarter of cases are caused by a genetic disorder, [11] and about 5% of cases are ...
Disability advocates considered the Court decision to be a "substantial victory for families of children with disabilities." [52]: 6 Amendments were made in the Education Flexibility Partnership Act of 1999 to increase IDEA funding as a result of the case. [52]: 6
The increase in dose above threshold dose induces an increase in the percentage of biological responses. [2] Several benchmarks have been established to describe the effects of a particular dose of drug in a particular species, such as NOEL(no-observed-effect-level), NOAEL (no-observed-adverse-effect-level) and LOAEL (lowest-observed-adverse ...